PLA2G4A and Alzheimer disease: Since activated cPLA2 can target and hydrolyze phospholipids in cellular membranes, releasing ARA and lysophospholipids (Sun et al., 2014), it alters the composition, structure, and physical properties of cellular membranes, leading to changes in cell function relevant to AD pathology.